Abstract | Background: Methods: This study is a single-center, pilot, masked, randomized controlled trial conducted at the Muhimbili Orthopaedic Institute. Participants were randomized intraoperatively after wound closure to receive gentamicin solution or normal saline solution injected at the fracture site. Follow-ups were completed at 2 weeks, 6 weeks, 3 months, 6 months, 9 months, and 1 year postoperatively. The primary feasibility outcomes were the rate of enrollment and retention. The primary clinical outcome was the occurrence of fracture-related infection. Results: Of 199 patients screened, 100 eligible patients were successfully enrolled and randomized over 9 months (11.1 patients/month). Complete data were recorded at baseline and follow-up for >95% of cases. The rate of follow-up at 6 weeks, 3 months, 6 months, 9 months, and 1 year were 70%, 68%, 69%, 61%, and 80%, respectively. There was no difference in adverse events or any of the measured primary and secondary outcomes. Conclusion: This pilot study is among the first to evaluate locally administered gentamicin in open tibial fractures. Results indicate a rigorous clinical trial with acceptable rates of enrollment and follow-up to address this topic is possible in this setting.
|
Authors | Billy T Haonga, Patrick Ngunyale, Ericka P von Kaeppler, Claire A Donnelley, Nae Y Won, Edmund N Eliezer, Kelsey Brown, Michael Flores, Jamieson M O'Marr, Patricia Rodarte, Mayur Urva, Abigail Cortez, Travis Porco, Saam Morshed, David W Shearer |
Journal | OTA international : the open access journal of orthopaedic trauma
(OTA Int)
Vol. 6
Issue 2
Pg. e268
(Jun 2023)
ISSN: 2574-2167 [Electronic] United States |
PMID | 37719315
(Publication Type: Journal Article)
|
Copyright | Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association. |